Concepedia

Hans Heemskerk

HH

Statistics

Publications

10

Citations

926

H-Index

10

Active since

2008

Affiliations

Leiden University Medical Center(Current)

ProQR Therapeutics (Netherlands)

University of Ferrara

Hans Heemskerk is an author at Leiden University Medical Center specializing in muscular dystrophy, exon skipping, and molecular biology.

Publications per year

2008–2013

10

Publications

10

Phage display screening without repetitious selection rounds

Peter A.C. ’t Hoen, Silvana M.G. Jirka, Bradley R. ten Broeke et al. · Analytical Biochemistry · 2011 · 174 citations · Full text

, , +13

<i>In vivo</i> comparison of 2′‐<i>O</i>‐methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping

Hans Heemskerk, C.L. de Winter, Sjef J. de Kimpe et al. · The Journal of Gene Medicine · 2009 · 171 citations · Full text

, , +13

Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms

Annemieke Aartsma‐Rus, Marscha Hirschi, Anneke A. M. Janson et al. · Molecular Therapy · 2008 · 147 citations · Full text

, , +17

Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model

Hans Heemskerk, Christa de Winter, Petra van Kuik et al. · Molecular Therapy · 2010 · 137 citations · Full text

, , +15

Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double‐knockout mice

Maaike van Putten, Margriet Hulsker, Courtney S. Young et al. · The FASEB Journal · 2013 · 116 citations · Full text

, , +15

1–5 of 10